Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Myfortic price, strengths & recalls

Brand of mycophenolic acid (generic)

Pharmacies pay $448.03 for 30 tablets of Myfortic 360 mg delayed-release tablet this week, and from $222.99 to $448.03 across its 2 priced strengths and forms. The generic, mycophenolic acid, costs pharmacies from $3.07. It has 3 recalls on record, none ongoing. Its official label last changed on August 11, 2026.

Brand
Pharmacies pay$448.03for 30 tablets of 360 mg delayed-release tabletNo change in 4 weeks
Fair cash price
$525.73
Strengths
2
Makers
1
Updated
Nov 11

Myfortic price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
180 mg delayed-release tablet Brand$7.43$222.99 / 30 tabletsNo change+3.2%
360 mg delayed-release tablet Brand$14.93$448.03 / 30 tabletsNo change+3.8%

Myfortic vs generic mycophenolic acid

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
180 mg delayed-release tablet$222.99$3.0772.7x
360 mg delayed-release tablet$448.03$6.4969x
GenericMycophenolic acid prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
1 ongoing recall3 recalls on record

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for myfortic? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 11, 2026
Version36 of 27
EffectiveJul 29, 2026
Read the label

These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC.MYFORTIC® (mycophenolic acid) delayed-release tablets, for oral useInitial U.S. Approval: 2004

This drug has a boxed warning

WARNING: EMBRYO-FETAL TOXICITY, MALIGNANCIES, AND SERIOUS INFECTIONS

Use during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning [see Warnings and Precautions (5.1), Use in Specific Populations (8.1, 8.3)].

Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe Myfortic. Patients receiving Myfortic should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient [see Warnings and Precautions (5.2)].

Increased risk of development of lymphoma and other malignancies, particularly of the skin, due to immunosuppression [see Warnings and Precautions (5.3)].

Increased susceptibility to bacterial, viral, fungal, and protozoal infections, including opportunistic infections [see Warnings and Precautions (5.4, 5.5)].

WARNING: EMBRYO-FETAL TOXICITY, MALIGNANCIES, and SERIOUS INFECTIONS

See full prescribing information for complete boxed warning

Use during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning. (5.1, 8.1, 8.3)

Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe Myfortic. (5.2)

Increased risk of development of lymphoma and other malignancies, particularly of the skin, due to immunosuppression. (5.3)

Increased susceptibility to bacterial, viral, fungal, and protozoal infections, including opportunistic infections. (5.4, 5.5)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA050791 · Novartis
First approved
February 27, 2004 (22 years ago)
Latest approved change
July 29, 2026
Approved label
PDF, Aug 4, 2026
Generic makers
9 approved generic applications on the market

Myfortic questions

How much does myfortic cost without insurance?

Pharmacies pay about $448.03 for 30 tablets of myfortic 360 mg delayed-release tablet ($14.93 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $525.73. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Myfortic?

Yes: mycophenolic acid. Pharmacies pay from $3.07 for it. Compare mycophenolic acid prices.

Is myfortic in shortage?

No shortage is reported for myfortic right now. We check the national shortage list every day.

Has myfortic been recalled?

3 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the myfortic label last change?

The official label was last updated on August 11, 2026 (version 36). See what changed.

Talk about myfortic

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.